Company / Current Assets
KalVista Pharmaceuticals, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$241.7M
FY2025
5-year range
$172.3M / $264.3M
FY2021-FY2025
Trend
+7.1%
vs FY2024
Sector context
#179 of 213
Health Care
What the data says
KalVista Pharmaceuticals, Inc.'s current assets of $242M is lower than 84% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 10 years, ranging from $25M in FY2016 to $264M in FY2021.
Based on SEC 10-K filings.
$242M in FY2025 with a 5-year CAGR of +22.2%.
Improved from $172M to $242M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 213This company $241.7M Sector average $2.5B
▼
-90.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, current assets increased 7.1% year-over-year.
- Ranks #179 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $241.7M | +7.1% |
| FY2024 | $225.7M | +31.0% |
| FY2023 | $172.3M | -11.0% |
| FY2022 | $193.6M | -26.7% |
| FY2021 | $264.3M | +197.9% |
| FY2020 | $88.7M | -23.2% |
| FY2019 | $115.5M | +94.6% |
| FY2018 | $59.4M | +73.6% |
| FY2017 | $34.2M | +38.6% |
| FY2016 | $24.7M | -55.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026